Teva Adds Needed LatAm Puzzle Piece With Rimsa Buy
This article was originally published in Scrip
Executive Summary
Teva Pharmaceutical Industries Ltd seems to have outbid a number of rivals to win Mexican drugmaker Rimsa for $2.3bn cash, a move which will bolster the Israeli generics giant's presence in Latin America and position it for further acquisitions in that fast growing region.